The Pharmaceutical giant say they are taking steps to resolve a multi-billion dollar cancer-related lawsuit with thousands of ...

Plaintiffs have three months to vote on whether to approve a proposed legal settlement that would resolve nearly all talc ...

Deal would resolve tens of thousands of lawsuits alleging company’s baby powder causes ovarian cancer ...

Johnson & Johnson, which began selling Baby Powder in 1894, will end all sales of the talc-based product next year. Johnson & Johnson (JNJ) shares edged lower Friday after the consumer ...

A subsidiary of Johnson & Johnson is now proposing paying approximately $6.48 billion over 25 years as part of a settlement ...

Even looking at the nominal value of the latest potential talc-settlement—approximately $8.4 billion, which is then ...

Johnson & Johnson and Kenvue Inc. were ordered to pay $45 million to the family of an Illinois woman who blamed the companies ...

(Reuters) - Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended U.S. sales of a product that drew ...

There have been varied opinions from researchers and government agencies if talc-based powders increase the risk of ovarian ...

On April 16, Johnson & Johnson reported first-quarter earnings of $2.71 per share, beating FactSet's consensus of $2.66.

J&J now faces almost 60,000 suits blaming talc used in baby power and similar products for ... The consolidated case is In Re ...

In 2019:Johnson & Johnson recalls baby powder after discovering small amounts of asbestos Keep reading:Johnson & Johnson to end sales of talc baby powder globally next year amid cancer lawsuits ...